New FDA Drug for Diabetes Eye Condition

New FDA Drug for Diabetes Eye Condition

By editor
March 31, 2015

Health Day News The U.S. Food and Drug Administration on March, 2015 approved the use of Eylea, an injected drug, to treat diabetic retinopathy in patients with diabetic macular edema. According to the U.S. Centers for Disease Control and Prevention, diabetic retinopathy is a leading cause of blindness in American adults. A third of those over...  read more